Final - June 15, 2016

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

PURPOSE PRESIDER/PRESENTER(s)

Dr. Nancy Bennett (ACIP Chair)

Dr. Amanda Cohn (ACIP Executive 

Secretary; CDC)

8:30 Agency Updates

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NIH, NVPO Information Dr. Nancy Messonnier (CDC/NCIRD); CDC 

and Ex Officio M embers

8:45 Cholera Vaccine

Introduction

Cholera vaccine updates

Proposed recommendations

Public Comment

Recommendation Vote

Dr. Art Reingold (ACIP, WG Chair)

Dr. Karen Wong (CDC/NCEZID)

Dr. Karen Wong (CDC/NCEZID)

Dr. Karen Wong (CDC/NCEZID)

10:00 Break

10:30 Meningococcal Vaccines

Introduction

Update: Trumenba Label

Summary of WG Discussions: Trumenba Label

Cost-effectiveness of MenACWY in HIV-Infected Persons

GRADE for MenACWY in HIV-Infected Persons 

Considerations for Use of MenACWY in HIV-Infected Persons

Proposed recommendations

Public Comment

Recommendation Vote

VFC Vote

Dr. Lorry Rubin (ACIP, WG Chair)

Dr. Laura York (Pfizer)

Ms. Jessica MacNeil (CDC/NCIRD)

Dr. Ismael Ortega-Sanchez (CDC/NCIRD)

Dr. Monica Patton (CDC/ NCIRD)

Ms. Jessica MacNeil (CDC/NCIRD)

Ms. Jessica MacNeil (CDC/NCIRD)

Ms. Jessica MacNeil (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

12:40 Lunch

2:00 Evidence-Based Recommendations Work Group Update Information Dr. Art Reingold (ACIP, WG Chair)

Dr. Wendy Carr (CDC/NCIRD)

2:05 Hepatitis Vaccines Update Information

Information

Dr. Art Reingold (ACIP, WG Chair)

Dr. Noele Nelson (CDC/NCHHSTP)

2:10 Vaccine Supply Dr. Jeanne Santoli (CDC/NCIRD)

2:20 Influenza

Introduction

Flulaval quadrivalent 

Flucelvax Quadrivalent

Vaccine safety update

Dr. Ruth Karron (ACIP, WG Chair)

Dr. Bruce Innis (GSK)

Dr. James Mansi (Seqirus)

Dr. Tom Shimabukuro (CDC/NCEZID)

3:10 Break

3:30 Vaccine effectiveness update

Proposed recommendations summary

Public Comment

Recommendation Vote

VFC Vote

Dr. Brendan Flannery (CDC/NCIRD) 

Dr. Chris Ambrose (MedImmune)

Dr. Lisa Grohskopf (CDC/NCIRD)

Dr. Lisa Grohskopf (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

Vote

VFC Vote

5:00 Public Comment

5:15 Adjourn

Information & 

Discussion

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30329 

June 22-23, 2016

AGENDA ITEM

Wednesday, June 22

8:00 Welcome & Introductions

Information & 

Discussion

Vote

Information & 

Discussion

 

Vote

VFC Vote

page 1 of 2
Final - June 15, 2016

Thursday, June 23

8:00 Unfinished business

8:30 Respiratory Syncytial Virus (RSV) Vaccine – Older Adults

Introduction

Overview of RSV Vaccines

Dr. Ruth Karron (ACIP, WG Chair)

Dr. Lindsay Kim (CDC/NCIRD)

9:00 Safety of Maternal Tetanus, Diphtheria, Acellular Pertussis (Tdap) 

Immunization

Introduction and enhanced surveillance of Tdap vaccine safety in 

pregnancy in VAERS

Maternal pertussis vaccination and structural birth defects in 

offspring

Reactogenicity and immunogencity of Tdap vaccine in pregnant 

women

Pertussis Vaccines Work Group Update

Dr. Pedro Moro (CDC/NCEZID)

Dr. Lakshmi Sukumaran (CDC/NCEZID)

Dr. Kathryn M. Edwards (Vanderbilt 

University School of Medicine)

Dr. Art Reingold (ACIP, WG Chair) 

9:55 Break

10:25 Laboratory Containment of Poliovirus Type 2 Information & 

Discussion

Dr. Olen Kew, National Poliovirus 

Containment Coordinator

10:40 Human Papillomavirus (HPV) Vaccines

Introduction

HPV vaccine duration of protection 

Modeling and cost effectiveness of 2-dose vaccination schedules

HPV vaccine effectiveness studies 

GRADE for 2-dose schedules

Recommendation options

Dr. Allison Kempe (ACIP, WG Chair)

TBD

Dr. Marc Brisson (Laval University)

Dr. Sara Oliver (CDC/NCIRD)

Dr. Elissa Meites (CDC/NCIRD)

Dr. Lauri Markowitz (CDC/NCIRD)

12:45 Public Comment

1:00 Adjourn

Acronyms

CDC

CMS

DoD

DVA

Tdap

FDA

GRADE

HRSA

IHS

LAIV

MSM

NCHHSTP

NCIRD

NCEZID

NIH

NVPO

VFC

WG

Information & 

Discussion 

Information & 

Discussion

Grading of Recommendations Assessment, Development and Evaluation

Centers for Medicare and Medicaid Services 

Centers for Disease Control & Prevention

Food and Drug Administration

Department of Veterans Affairs

Department of Defense

Tetanus, Diphtheria, Acellular Pertussis Vaccine

Work Group

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

Vaccines for Children

Health Resources and Services Administration

Indian Health Service

National Institutes of Health

National Vaccine Program Office

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

Men who have sex with men

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

Live Attenuated Influenza Vaccine

Information & 

Discussion

page 2 of 2